| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2008 | A general model for sequential pattern mining with a progressive database | Huang J.-W.; Tseng C.-Y.; Ou J.-C.; Chen M.-S.; MING-SYAN CHEN | IEEE Transactions on Knowledge and Data Engineering | 57 | 33 | |
| 2012 | Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity | Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN ; Kim I.; Shiau C.-W. | European Journal of Medicinal Chemistry | 63 | 61 | |
| 2021 | Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel | Huang J.-W.; CHING-HUA KUO ; Kuo H.-C.; JIN-YUAN SHIH ; Tsai T.-W.; LIN-CHAU CHANG | PLoS ONE | 4 | 3 | |
| 2018 | Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023)) | Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN ; Kim I.; Shiau C.-W. | European Journal of Medicinal Chemistry | 1 | 1 | |
| 2017 | Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2011) 55(5) (1041–1048)(S0168827811001917)(10.1016/j.jhep.2011.01.047)) | Tai W.-T.; ANN-LII CHENG ; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN ; Chen K.-F. | Journal of Hepatology | 1 | 1 | |
| 2017 | Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007)) | Tai W.-T.; ANN-LII CHENG ; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN ; Chen K.-F. | Journal of Hepatology | 0 | 1 | |
| 2006 | Development of small-molecule cyclin D1-ablative agents | Huang J.-W.; Shiau C.-W.; Yang J.; Wang D.-S.; HAO-CHIEH CHIU ; Chen C.-Y.; Chen C.-S. | Journal of Medicinal Chemistry | 51 | 47 | |
| 2021 | Differences in Fatty Acid Oxidation between Nab-Paclitaxel- And Solvent-Based Paclitaxel-Treated A549 Cells Based on Metabolomics | Huang J.-W.; CHING-HUA KUO ; Kuo H.-C.; JIN-YUAN SHIH ; Tsai T.-W.; LIN-CHAU CHANG | ACS Omega | 2 | 2 | |
| 2014 | Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma | Tai W.-T.; Shiau C.-W.; PEI-JER CHEN ; Chu P.-Y.; HSIANG-PO HUANG ; Liu C.-Y.; Huang J.-W.; Chen K.-F. | Hepatology | 54 | 55 | |
| 2020 | Effects of nanomaterials on seedling growth and disease control | Chang P.-F.L; Chang T.-H; Liu Y.-W; Chen C.-C; Li W.-Y; Chung W.-H; Lin J.-J; Huang J.-W.; JIANG-JEN LIN | Acta Horticulturae | 0 | 0 | |
| 2014 | Green Purchasing by MNC Subsidiaries: The Role of Local Tailoring in the Presence of Institutional Duality | Hsu P.-F; Hu P.J.-H; Wei C.-P; Huang J.-W.; CHIH-PING WEI | Decision Sciences | 24 | 19 | |
| 2007 | How organizational climate and structure affect knowledge management-The social interaction perspective | Chen C.-J.; Huang J.-W.; CHUNG-JEN CHEN | International Journal of Information Management | 374 | 311 | |
| 2013 | Interaction between lung cancer cell and myofibroblast influenced by cyclic tensile strain | Huang J.-W.; Pan H.-J.; Yao W.-Y.; Tsao Y.-W.; WEI-YU LIAO ; Wu C.-W.; Tung Y.-C.; Lee C.-H. | Lab on a Chip | 17 | 16 | |
| 2010 | Knowledge management and innovativeness: The role of organizational climate and structure | Chen C.-J.; Huang J.-W.; Hsiao Y.-C.; CHUNG-JEN CHEN | International Journal of Manpower | 197 | 146 | |
| 2019 | The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label | Wang Y.-H.; Chen C.-B.; Tassaneeyakul W.; Saito Y.; Aihara M.; Choon S.E.; Lee H.Y.; Chang M.M.; Roa F.D.; Wu C.-W.; Zhang J.; Nakkam N.; Konyoung P.; Okamoto-Uchida Y.; Cheung C.M.-T.; Huang J.-W.; Ji C.; Cheng B.; Hui R.C.-Y.; CHIA-YU CHU ; Chen Y.-J.; Wu C.-Y.; Hsu C.-K.; Chiu T.-M.; Huang Y.-H.; Lu C.-W.; Yang C.-Y.; Lin Y.-T.; Chi M.-H.; Ho H.-C.; Lin J.-Y.; Yang C.-H.; Chang Y.-C.; Su S.-C.; Wang C.W.; Fan W.-L.; Hung S.-I.; Chung W.-H.; for the Asian Severe Cutaneous Adverse Reaction Consortium | Clinical Pharmacology and Therapeutics | 42 | 40 | |
| 2011 | Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting | TAO-MIN HUANG ; VIN-CENT WU ; Young G.-H.; YU-FENG LIN ; Shiao C.-C.; Wu P.-C.; WEN-YI LI ; HSI-YU YU ; Lin J.-W.; Chen Y.-S.; YIH-SHARNG CHEN ; YEN-HUNG LIN ; SHOEI-SHEN WANG ; RON-BIN HSU ; FAN-CHI CHANG ; NAI-KUAN CHOU ; TZONG-SHINN CHU ; Tsai P.-R.; Huang J.-W.; JENQ-WEN HUANG ; SHUEI-LIONG LIN ; YUNG-MING CHEN ; Ko W.-J.; Wu K.-D. | Journal of the American Society of Nephrology | 132 | 122 | |
| 2014 | SC-60, a dimer-based sorafenib derivative, shows a better anti-hepatocellular carcinoma effect than sorafenib in a preclinical hepatocellular carcinoma model | Tai W.-T.; Shiau C.-W.; Li Y.-S.; Chen Y.-L.; Chu P.-Y.; Huang J.-W.; Hsu C.-Y.; Hsu Y.-C.; PEI-JER CHEN ; Chen K.-F. | Molecular Cancer Therapeutics | 6 | 6 | |
| 2011 | Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma | Tai W.-T.; ANN-LII CHENG ; Shiau C.-W.; HSIANG-PO HUANG ; Huang J.-W.; PEI-JER CHEN ; Chen K.-F. | Journal of Hepatology | 141 | 137 | |
| 2011 | Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf | Chen K.-F.; Tai W.-T.; Huang J.-W.; Hsu C.-Y.; Chen W.-L.; ANN-LII CHENG ; PEI-JER CHEN ; Shiau C.-W. | European Journal of Medicinal Chemistry | 31 | 26 | |
| 2009 | Strategic human resource practices and innovation performance - The mediating role of knowledge management capacity | Chen C.-J.; Huang J.-W.; CHUNG-JEN CHEN | Journal of Business Research | 886 | 752 |
